Fluoxetine Mitigation Mental Health Study for Patients With Musculoskeletal Trauma

PHASE2CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

February 17, 2025

Study Completion Date

February 17, 2025

Conditions
Musculoskeletal Injury
Interventions
DRUG

Fluoxetine

Subjects will be randomized to take Fluoxetine (10mg by mouth per day). The randomized drug will be prescribed by the orthopedic team on the day randomization so that the patient may be monitored for side effects during the remainder of their hospitalization. The patient will be prescribed the randomized medication on the day of discharge and a 90 day supply will be provided by the inpatient research pharmacy.

DRUG

Calcium

Subjects will be randomized to take Calcium supplementation (1000mg by mouth per day). The randomized drug will be prescribed by the orthopedic team on the day randomization so that the patient may be monitored for side effects during the remainder of their hospitalization. The patient will be prescribed the randomized medication on the day of discharge and a 90 day supply will be provided by the inpatient research pharmacy.

Trial Locations (1)

32608

University of Florida, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER

NCT04850222 - Fluoxetine Mitigation Mental Health Study for Patients With Musculoskeletal Trauma | Biotech Hunter | Biotech Hunter